In the first two studies, following administration of 7.2 mg of OM-85-active principle, for 10 days, an increase of influenza-specific NP-tetramer+ CD8+ cytotoxic T-cell proportions in BAL fluid were associated with a reduced viral replication and a faster viral clearance (23, 36). Here, CD8A is linked to influenza.